Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Immunol. 2015 Feb 20;194(7):3487–3500. doi: 10.4049/jimmunol.1401717

Fig. 5. The structural and functional avidity range of A2/MART1 TCRs consisting of SIG35α is very broad and further enhanced by the presence of CD8.

Fig. 5

Jurkat 76 cells, which lack the expression of CD8αβ and endogenous TCRs, were retrovirally transduced with CD8αβ to produce Jurkat 76/CD8αβ. Jurkat 76 or Jurkat 76/CD8αβ cells were individually transduced with eleven distinct TRBV27 TCRβ chains along with SIG35α or with DMF5αβ chains. (A), A2/MART1 TCRs reconstituted on Jurkat 76 or Jurkat 76/CD8αβ cells were differentially stained by A2/MART1 multimer. All Jurkat 76 or Jurkat 76/CD8αβ transfectants were stained with 2 μg/ml A2/MART1 or A2/HIV multimer along with anti-CD3 mAb (top) or anti-CD8 mAb (bottom). Data for multimer staining of seven representative Jurkat 76 or Jurkat 76/CD8αβ transfectants are shown. Data for multimer staining of the remaining 5 transfectants are shown in Supplementary Fig. 3. (B), Reconstituted A2/MART1 TCRs are highly avid for A2/MART1 recognition. IL-2 ELISPOT assays were performed using seven representative Jurkat 76 or Jurkat 76/CD8αβ transfectants as responder cells. T2 cells pulsed with 10 μg/ml wild-type A2/MART1 or A2/HIV control peptide were used as stimulator cells (left). The A2+ MART1 melanoma line, A375, and the A2+ MART1+ melanoma line, Malme-3M were used as stimulator cells (right). All experiments were conducted in triplicate and error bars show SD. Data shown are representative of two independent experiments. (C), Reconstituted A2/MART1 TCRs possess a broad range of functional and structural avidities. Functional avidities of Jurkat 76 or Jurkat 76/CD8αβ cells expressing 11 different A2/MART1 TCRβ chains paired with SIG35α and DMF5 are depicted as % IL-2 secreting abilities determined by IL-2 ELISPOT assays using T2 cells pulsed with graded concentrations of wild-type A2/MART1 peptide as stimulator cells (left). Structural avidities of the same transfectants are shown as multimer staining percentages determined by staining with graded concentrations of A2/MART1 multimer (right). Data shown are representative of two independent experiments.

HHS Vulnerability Disclosure